Page last updated: 2024-11-04

streptonigrin and Epithelial Ovarian Cancer

streptonigrin has been researched along with Epithelial Ovarian Cancer in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Platinum-resistant ovarian cancer is one of the most common and refractory gynecologic cancers around the world."2.82Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study. ( Gou, W; Guo, J; Hou, W; Li, Y; Liu, Q; Ning, H; Shang, H; Sun, X; Wei, H, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wei, H1
Guo, J1
Sun, X1
Gou, W1
Ning, H1
Shang, H1
Liu, Q1
Hou, W1
Li, Y1

Reviews

1 review available for streptonigrin and Epithelial Ovarian Cancer

ArticleYear
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
    Journal of natural products, 2022, 05-27, Volume: 85, Issue:5

    Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Cysteine Endopeptidases; Drug Resistance

2022